Long-term outcomes in incident pulmonary arterial hypertension (PAH) patients initiated with triple combination therapy including parenteral prostacyclin (PGI2)

The ERS International Congress 2020, Virtual

This annual event brings together the world's respiratory experts to showcase all the latest advances in respiratory medicine and science.

Due to the COVID-19 pandemic, in 2020 the ERS International Congress took place for the first time in a completely virtual format.

Updated assessment and treatment of pulmonary arterial hypertension

Chair(s): M. Hoeper (Hannover, Germany), S. Gaine (Dublin, Ireland)

Session type: Oral Presentation

Long-term outcomes in incident pulmonary arterial hypertension (PAH) patients initiated with triple combination therapy including parenteral prostacyclin (PGI2)

A. Boucly (Le Kremlin Bicètre, France), A. Baron (Le Kremlin Bicètre, France), L. Savale (Le Kremlin Bicètre, France), X. Jaïs (Le Kremlin Bicètre, France), F. Picard (Bordeaux, France), V. Cottin (Lyon, France), E. Bergot (Caen, France), C. Dauphin (Clermont-Ferrand, France), A. Bourdin (Montpelliernt-Ferrand, France), A. Chaouat (Nancy, France), P. Roblot (Dijon, France), C. Chabanne (Rennes, France), G. Prévot (Toulouse, France), L. Bertoletti (Saint-Etienne, France), D. Montani (Le Kremlin Bicètre, France), G. Simonneau (Le Kremlin Bicètre, France), M. Humbert (Le Kremlin Bicètre, France), O. Sitbon (Le Kremlin Bicètre, France)

CDN Connection Issue

The ERS International Congress 2020, Virtual

Limited Access

#{title}